Your Thyroid Problem Is Actually A Conversion Problem

May 20, 2026
Your Thyroid Problem Is Actually A Conversion Problem

Your thyroid makes mostly T4, and T4 is not the hormone that actually does anything in your cells.

T4 is a storage hormone, a form of thyroid hormone your body holds in reserve, waiting to be converted into something usable. The usable form is called T3, which is the active hormone that actually enters your cells and controls metabolism, energy, heart rate, body temperature, and dozens of other functions. Your thyroid does make some T3 directly, but between 70 and 90 percent of the T3 circulating in your blood comes from outside the thyroid entirely. It comes from conversion that happens in your liver, your kidneys, and your skeletal muscle.

That is the map. Your thyroid produces T4, your peripheral tissues convert it to T3, and your cells run on T3. Everything else in this article is about what happens when that middle step breaks down.

The enzyme doing the conversion work is called a deiodinase, which is a protein that strips an iodine atom off T4 to create T3. There are different versions. Type 1 deiodinase runs primarily in the liver and kidneys, handling the bulk of systemic conversion. Type 2 deiodinase is concentrated more in skeletal muscle and the brain, and it converts T4 locally for those tissues. The reason this matters is that skeletal muscle is not a passive bystander in your thyroid system. The more muscle tissue you carry, the more Type 2 deiodinase activity you have, and the more surface area your body has to convert T4 into usable T3.

Training is not just good for your metabolism in a vague, general sense. It directly expands the organ system responsible for making active thyroid hormone.

Now here is where the diagnostic picture gets complicated, and where most standard thyroid workups fall short. The number doctors typically check is TSH, which stands for thyroid stimulating hormone and is a signal your pituitary gland sends to your thyroid to tell it to produce more hormone. TSH is useful as a first screen, but it only tells you about the feedback loop between your pituitary and your thyroid. It tells you nothing about whether T4 is actually being converted into T3 in your peripheral tissues, and it tells you nothing about a problem called reverse T3, which is an inactive form of the hormone that gets made from T4 under certain conditions and blocks T3 from doing its job.

A 2011 study looked at patients who had their thyroid completely removed and were being managed on standard levothyroxine, which is a synthetic T4 medication, and the researchers found that more than 20 percent of those patients had abnormal free T3 or free T4 levels even when their TSH was reading as normal. The pituitary feedback loop looked fine. The actual hormone levels were not. That is not a minor edge case. That is one in five patients who would be told their labs are normal and their symptoms are not thyroid related, when in reality their conversion was broken.

The things that break conversion are not mysterious. Chronically elevated cortisol, which your body produces in response to stress, suppresses deiodinase activity and also pushes T4 toward making reverse T3 instead of active T3. Low protein intake removes the raw material the conversion enzymes need to function. Selenium deficiency specifically impairs deiodinase activity because selenium is a structural component of those enzymes, not just a nutrient they consume. Inflammation from conditions like Hashimoto's thyroiditis creates the same kind of cortisol and cytokine environment that shuts conversion down.

This is why the fix is often not more T4. If someone is converting T4 poorly, giving them more T4 just gives their broken conversion system more substrate to work with, and in some cases more raw material to make reverse T3.

The lifestyle levers work through real mechanisms. A 2025 cross-sectional study of patients with Hashimoto's thyroiditis found that those who exercised regularly had significantly lower inflammatory markers compared to sedentary patients with the same diagnosis. Lower inflammation means less suppression of deiodinase activity, which means better conversion. A separate 2025 case report documented a patient with Hashimoto's who followed a structured high-protein protocol and saw meaningful resolution of symptoms alongside improvements in thyroid antibodies.

Protein matters here for two reasons. First, the amino acid tyrosine is one of the building blocks your thyroid uses to actually synthesize thyroid hormones, so chronically low protein intake can limit production at the source. Second, adequate protein supports muscle mass, and as already established, muscle is where a significant portion of T4-to-T3 conversion happens.

If lifestyle changes do not fully resolve symptoms, the next step is not automatically more levothyroxine. A 2022 trial found that hypothyroid patients with residual symptoms on levothyroxine therapy reported meaningful improvements in quality of life when a small amount of T3, called liothyronine, was added to their protocol. These were patients whose TSH was already in range on T4 alone. The TSH looked fine. The patient did not feel fine. Adding T3 directly bypassed the conversion problem entirely.

The current American Thyroid Association guidelines recommend TSH as the primary monitoring tool and do not call for routine measurement of free T3 or reverse T3. That is a reasonable population-level position for screening purposes, but it creates a diagnostic blind spot for anyone whose problem lives in the conversion step rather than in thyroid production itself.

This is why the standard advice, which says "your TSH is normal so your thyroid is fine," can be wrong in a technically accurate way. The pituitary feedback loop may be responding normally to circulating T4 levels, but if that T4 is not being converted into T3 efficiently, or if it is being routed into reverse T3 instead, the feedback system has no way to detect that and neither does a single TSH number.

The thyroid gland is not the whole system. It is the beginning of the system, and in most people with suboptimal thyroid function, the problem is downstream of it.


References

  1. Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R. (2011). Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients. PLoS ONE 6(8):e22552. PMC3148220.
  2. Cited for: the >20% of patients with abnormal FT3 or FT4 despite normal TSH on levothyroxine.
  3. Limbaugh SL, Ennessy LA, Davis KS, Allen VT. (2025). Nutrition Based, High Protein Adjunct Therapy for Hashimoto's Thyroiditis: A Case Report. Cureus 17(9):e91597. PMC12495900.
  4. Cited for: protein protocol resolving Hashimoto's symptoms.
  5. Vuletić M, Žnidar V, Barić Žižić A, et al. (2025). Recreational Exercise and Inflammatory Patterns in Hashimoto's Thyroiditis: Observations from a Cross Sectional Study. Biomolecules 15(11):1510. PMC12650045.
  6. Cited for: exercise reducing inflammatory markers in Hashimoto's patients.
  7. Bjerkreim BA, Hammerstad SS, Gulseth HL, et al. (2022). Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy. Frontiers in Endocrinology 13:816566. PMC8902821.
  8. Cited for: clinical evidence that adding T3 improves quality of life in patients with residual symptoms.
  9. Lindner HH. (2025). Clinical thyroidology: beyond the 1970s' TSH T4 Paradigm. Frontiers in Endocrinology 16:1529791. PMC12234311.
  10. Cited for: critique of the TSH only diagnostic model. Note: single author opinion piece.
  11. European Thyroid Journal. Role of hepatic deiodinases in thyroid hormone homeostasis. PMC10160546.
  12. Cited for: D1 distribution in liver and kidney, D2 distribution in skeletal muscle.
  13. ScienceDirect Topics. Thyroxine Deiodinase.
  14. Cited for: the 70-90 percent peripheral conversion figure.
  15. Pituitary Foundation. Hormone Replacement Medication Interactions.
  16. Cited for: thyroid hormone status affecting IGF-1 levels.
  17. American Thyroid Association Guidelines on Treatment of Hypothyroidism.
  18. Cited for: current guideline recommending TSH for monitoring without routine FT3 or rT3 testing.

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness

If this is the kind of information you want access to on a daily basis, the community is free and there are full courses on training, nutrition, hormones, and supplementation inside. You can ask questions and post your own labs and get feedback from me and from the community.